The Detmold Medical story is an incredible one. It’s a story of bold decisions, collaborations, and jumbo jets. Most of all, it’s a story of entrepreneurial spirit and teamwork that enabled us to achieve an 18-month project in 18 weeks, driven by a collective purpose: to take care of those who care.
The Call To Arms
In February 2020, the SA and Federal Governments approached the Detmold Group to secure a reliable supply of locally manufactured Face Mask Personal Protection Equipment (PPE) to safeguard Australia’s frontline healthcare professionals.
It was a call to arms we answered, and Detmold Medical was born. We committed to producing 145 million face masks, extending our manufacturing capabilities into a new direction to help fight COVID-19.
Mask Manufacturing In The Time Of COVID
As an Australian family-owned business and global packaging manufacturing specialists, we quickly pivoted to face mask production thanks to our existing innovation, procurement, engineering, and supply chain capabilities.
By March 2020, Australia’s borders had closed. Due to global freight issues, we hired jumbo jets to import 20 new specialist mask manufacturing machines. We also procured the face masks’ vital raw material from Australian family-owned Tacca Medical. This removed overseas reliance on a scarce mask ingredient with unpredictable delivery schedules and pricing.
Collaborating With Experts. Investing In People.
We immediately established the technical and administrative gaps in our expertise and collaborated with universities, research labs and the State Government to set up a TGA-certified mask manufacturing facility with onsite face mask testing – an Australian first.
17 Detmold Group employees were seconded and upskilled in face mask estimating, engineering, procurement, supply chain, human resources and quality control. We also employed over 200 South Australians, many of whom had been let go from previous roles due to the pandemic.